BDTX · NASDAQ · Biotechnology

Black Diamond Therapeutics

Develops brain-penetrant therapies for EGFR-mutant lung cancer and glioblastoma.

$2.23
After-hours close0.00 (0.00%)
At close$2.23(−1.76%)
DateEstimateReportedSurprise
Nov 2026−$0.06
Aug 2026−$0.20−$0.17+13.0%
Aug 2026−$0.20−$0.17+13.0%
May 2026−$0.18−$0.16+11.1%
Mar 2026−$0.18−$0.14+22.2%

The latest year is open to everyone — the 31 quarters behind it read with an account.

Sign in
Nov 2025
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Feb 2020
Jun 2019
Mar 2019
Dec 2018
Sep 2018
Jun 2018
Mar 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026−$0.06$8.3M
Aug 6, 2026−$0.20−$0.17+13.0%
Aug 5, 2026−$0.20−$0.17+13.0%$5.6M
May 7, 2026−$0.18−$0.16+11.1%$25.0M
Mar 16, 2026−$0.18−$0.14+22.2%$9.4M

The latest year is open to everyone — the 31 quarters behind it read with an account.

Sign in
Nov 6, 2025
Aug 7, 2025
May 12, 2025
Mar 6, 2025
Nov 5, 2024
Aug 6, 2024
May 9, 2024
Mar 12, 2024
Nov 6, 2023
Aug 11, 2023
May 9, 2023
Mar 9, 2023
Nov 8, 2022
Aug 9, 2022
May 11, 2022
Mar 17, 2022
Nov 8, 2021
Aug 12, 2021
May 7, 2021
Mar 25, 2021
Nov 10, 2020
Aug 11, 2020
May 12, 2020
Mar 24, 2020
Feb 3, 2020
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018